Indeed, co-inhibition of glutamine synthetase (GLUL) in CAFs and glutaminase (GLS) in ovarian cancer cells abrogated cancer cell growth better than each individual treatment [38]. This evidence concerns the gene GLS and ovarian carcinoma.